{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:46:36Z","timestamp":1784868396250,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective or purpose<\/jats:title>\n                    <jats:p>\n                      To evaluate the diagnostic performance and agreement of the EyeArt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Artificial Intelligence (AI) system for detecting Diabetic Retinopathy (DR), comparing its results with ophthalmologists\u2019 assessments in a regional screening program.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects, participants, and\/or controls<\/jats:title>\n                    <jats:p>A total of 498 diabetic patients aged 18 years or older were enrolled between June and September 2023 through the Retisalud DR screening program in the Canary Islands. No separate control group was included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All participants underwent non-mydriatic fundus photography using the TRC-NW400 camera. Retinal images were analyzed by the EyeArt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      AI system (version 2.1.0), and results were compared with assessments by ophthalmologists based on the International Clinical Diabetic Retinopathy scale (ICDR). Agreement was quantified using Cohen\u2019s kappa coefficient. Additionally, mixed-effects logistic regression was used to explore associations between DR and clinical risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Sensitivity, specificity, and agreement (Cohen\u2019s kappa) of the AI system compared to clinical diagnosis; predictors of DR such as age, diabetes duration, presence of Diabetic Macular Edema (DME), and central retinal thickness (CRT-OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The EyeArt\u00ae system achieved a binocular sensitivity of 100% (95% CI: 98.1\u2013100) and a specificity of 93.5% (95% CI: 90.2\u201396.0). Agreement with ophthalmologist grading was excellent, with kappa values of 0.966 (right eye) and 0.978 (left eye). Younger age, longer diabetes duration, DME presence, and higher CRT were significantly associated with DR diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The EyeArt\n                      <jats:sup>\u00ae<\/jats:sup>\n                      AI system showed excellent diagnostic accuracy and strong agreement with clinical evaluations in DR screening. Nonetheless, its tendency to overestimate DR severity indicates the need for further refinement of its grading algorithm. These findings support the potential integration of AI systems into large-scale DR screening programs, pending further validation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00748-4","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:53:35Z","timestamp":1763546015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the degree of agreement in the diagnosis of diabetic retinopathy between ophthalmologists and EyeArt\u00ae"],"prefix":"10.1186","volume":"11","author":[{"given":"Isabel Inmaculada Guedes","family":"Guedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Saavedra Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Cabrera","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Ramos","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Ramos","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoze Gonz\u00e1lez","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"3","key":"748_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JWY Yau","year":"2012","unstructured":"Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012, Mar;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"128","key":"748_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"1","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. Idf diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017, Jun;1(128):40\u201350.","journal-title":"Diabetes Res Clin Pract"},{"issue":"138","key":"748_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"1","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. Idf diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018, Apr;1(138):271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"748_CR4","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli M V, et al. Global causes of blindness and distance vision impairment 1990-2020. A systematic review and meta-analysis. Lancet Glob Health. 2017, Dec, 1;5(12):e1221\u201334.","journal-title":"Lancet Glob Health"},{"key":"748_CR5","doi-asserted-by":"crossref","unstructured":"Fox CR, Kronenberg K, Weiskopf ES. Using telemedicine to increase eye care screening & referral for people with diabetes article details. J Pub Health Issue Pract JPHIP [Internet]. 2019;3:137. Available from: https:\/\/doi.org\/jphip\/2019\/137.","DOI":"10.33790\/jphip1100137"},{"issue":"2","key":"748_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"key":"748_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/bjo.2009.176784","volume":"12","author":"AD Fleming","year":"2010","unstructured":"Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Br J Ophthalmol [Internet]. 2010;12:1606. Available from: https:\/\/hal.science\/hal-00578459v1.","journal-title":"Br J Ophthalmol [Internet]"},{"key":"748_CR8","unstructured":"Corner S, Mohamed Q, Mark Gillies MC, Wong TY. Clinical, review management of diabetic retinopathy a systematic review [Internet]. Available from: www.jama.com."},{"key":"748_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/ceo.12745","volume":"44","author":"S Lin","year":"2016","unstructured":"Lin S, Ramulu P, Lamoureux EL, Sabanayagam C. Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review. Clin Exp Ophthalmol. 2016;44:300\u201320. Blackwell Publishing.","journal-title":"Clin Exp Ophthalmol"},{"key":"748_CR10","doi-asserted-by":"crossref","unstructured":"Zhang W, Zhao G, Fan W, Zhao T. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study. BMC Ophthalmol. 2021, Dec, 1;21(1).","DOI":"10.1186\/s12886-021-01920-8"},{"key":"748_CR11","unstructured":"Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, et al. Diabetic Retinopatiiy."},{"key":"748_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/OPTH.S346065","volume":"16","author":"W Aljundi","year":"2022","unstructured":"Aljundi W, Suffo S, Munteanu C, Langenbucher A, Seitz B, Abdin AD. Intravitreal injection for diabetic macular edema as adjunctive therapy for proliferative diabetic retinopathy: a retrospective study. Clin Ophthalmol. 2022;16:135\u201343.","journal-title":"Clin Ophthalmol"},{"issue":"5\u20136","key":"748_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/09286586.2018.1501498","volume":"25","author":"A Lopez-Ramos","year":"2018","unstructured":"Lopez-Ramos A, Gomez-Bastar PA, Lansingh VC, Rodriguez-Gomez JA, Vargas-Fragoso V, Soria-Arellano FA, et al. Rapid assessment of avoidable blindness: prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014. Ophthalmic Epidemiol. 2018, Nov, 2;25(5\u20136):412\u201318.","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"748_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/09286586.2015.1099682","volume":"23","author":"AP Murchison","year":"2016","unstructured":"Murchison AP, Friedman DS, Gower EW, Haller JA, Lam BL, Lee DJ, et al. A multi-center diabetes eye screening study in community settings: study design and methodology. Ophthalmic Epidemiol. 2016, Mar, 3;23(2):109\u201315.","journal-title":"Ophthalmic Epidemiol"},{"key":"748_CR15","doi-asserted-by":"crossref","unstructured":"Bek T, Andersen N, Andresen J, Grauslund J, Hajari J, Schmidt Laugesen C, et al. Individualised screening for diabetic retinopathy with proliferative retinopathy and macular oedema as separate end points. Acta Ophthalmol. 2024, Sep, 1;102(6):627\u201334.","DOI":"10.1111\/aos.16637"},{"key":"748_CR16","doi-asserted-by":"crossref","unstructured":"Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44:260\u201377. Blackwell Publishing.","DOI":"10.1111\/ceo.12696"},{"key":"748_CR17","doi-asserted-by":"crossref","unstructured":"Ting DSW, Tan GSW. Telemedicine for diabetic retinopathy screening. JAMA Ophthalmol. American Medical Association; 2017;135:722\u201323.","DOI":"10.1001\/jamaophthalmol.2017.1257"},{"key":"748_CR18","doi-asserted-by":"crossref","unstructured":"Mansberger SL, Sheppler C, Barker G, Gardiner SK, Demirel S, Wooten K, et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015, May, 1;133(5):518\u201325.","DOI":"10.1001\/jamaophthalmol.2015.1"},{"key":"748_CR19","doi-asserted-by":"crossref","unstructured":"Avidor D, Loewenstein A, Waisbourd M, Nutman A. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review. Cost Eff Resour Alloc. 2020;18. BioMed Central Ltd.","DOI":"10.1186\/s12962-020-00211-1"},{"key":"748_CR20","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.4103\/ijo.IJO_1442_21","volume":"69","author":"K Ramasamy","year":"2021","unstructured":"Ramasamy K, Mishra C, Kannan NB, Namperumalsamy P, Sen S. Telemedicine in diabetic retinopathy screening in India. Indian J Ophthalmol. NLM (Medline). 2021;69:2977\u201386.","journal-title":"Indian J Ophthalmol"},{"key":"748_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ceo.14269","volume":"51","author":"X Li","year":"2023","unstructured":"Li X, Tan TE, Wong TY, Sun X. Diabetic retinopathy in China: epidemiology, screening and treatment trends-A review. Clin Exp Ophthalmol. 2023;51:607\u201326. John Wiley and Sons Inc.","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"748_CR22","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1001\/jamaophthalmol.2013.4694","volume":"131","author":"X Zhang","year":"2013","unstructured":"Zhang X, Beckles GL, Chou CF, Saaddine JB, Wilson MR, Lee PP, et al. Socioeconomic disparity in use of eye care services among us adults with age-related eye diseases: national health interview survey, 2002 and 2008. JAMA Ophthalmol. 2013, Sep;131(9):1198\u2013206.","journal-title":"JAMA Ophthalmol"},{"key":"748_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/08820538.2016.1154170","volume":"31","author":"C Fathy","year":"2016","unstructured":"Fathy C, Patel S, Sternberg P, Kohanim S. Disparities in adherence to screening guidelines for diabetic retinopathy in the United States: a comprehensive review and Guide for future directions. Semin Ophthalmol. 2016;31:364\u201377. Taylor and Francis Ltd.","journal-title":"Semin Ophthalmol"},{"key":"748_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1189-3","volume":"19","author":"V Bellemo","year":"2019","unstructured":"Bellemo V, Lim G, Rim TH, Tan GSW, Cheung CY, Sadda SV, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application. Curr Diab Rep. 2019;19:1. Current Medicine Group LLC.","journal-title":"Curr Diab Rep"},{"key":"748_CR25","doi-asserted-by":"crossref","unstructured":"Abr\u00e0moff MD, Roehrenbeck C, Trujillo S, Goldstein J, Graves AS, Repka MX, et al. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit Med. 2022;5. Nature Research.","DOI":"10.1038\/s41746-022-00621-w"},{"issue":"1","key":"748_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000486284","volume":"60","author":"MF N\u00f8rgaard","year":"2018","unstructured":"N\u00f8rgaard MF, Grauslund J. Automated screening for diabetic retinopathy - a systematic review. Ophthalmic Res. 2018, Jun, 1;60(1):9\u201317.","journal-title":"Ophthalmic Res"},{"key":"748_CR27","unstructured":"Kavitha DR, Student UG. Detection of diabetic retinopathy using retinal fundus photographs based on deep learning algorithm. Turk J Physiother Rehabil [Internet]. 32(2). Available from: https:\/\/www.turkjphysiotherrehabil.org."},{"key":"748_CR28","doi-asserted-by":"crossref","unstructured":"Wongchaisuwat N, Trinavarat A, Rodanant N, Thoongsuwan S, Phasukkijwatana N, Prakhunhungsit S, et al. In-person verification of deep learning algorithm for diabetic retinopathy screening using different techniques across fundus image devices. Transl Vis Sci Technol. 2021, Nov, 1;10(13).","DOI":"10.1167\/tvst.10.13.17"},{"issue":"11","key":"748_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/dia.2019.0164","volume":"21","author":"M Bhaskaranand","year":"2019","unstructured":"Bhaskaranand M, Ramachandra C, Bhat S, Cuadros J, Nittala MG, Sadda SR, et al. The value of automated diabetic retinopathy screening with the EyeArt system: a study of more than 100,000 consecutive encounters from people with diabetes. Diabetes Technol Ther. 2019, Nov, 1;21(11):635\u201343.","journal-title":"Diabetes Technol Ther"},{"key":"748_CR30","doi-asserted-by":"crossref","unstructured":"Lim JI, Regillo CD, Sadda SVR, Ipp E, Bhaskaranand M, Ramachandra C, et al. Artificial intelligence detection of diabetic retinopathy: subgroup comparison of the EyeArt system with ophthalmologists\u2019 dilated examinations. Ophthalmol Sci. 2023, Mar, 1;3(1).","DOI":"10.1016\/j.xops.2022.100228"},{"key":"748_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.oret.2018.10.014","volume":"3","author":"KB Nielsen","year":"2019","unstructured":"Nielsen KB, Lautrup ML, Andersen JKH, Savarimuthu TR, Grauslund J. Deep learning-based algorithms in screening of diabetic retinopathy: a systematic review of diagnostic performance. Ophthalmol Retina. 2019;3:294\u2013304. Elsevier Inc.","journal-title":"Ophthalmol Retina"},{"key":"748_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1218-2","volume":"19","author":"A Honasoge","year":"2019","unstructured":"Honasoge A, Nudleman E, Smith M, Rajagopal R. Emerging insights and interventions for diabetic retinopathy. Curr Diab Rep. 2019;19:1. Current Medicine Group LLC.","journal-title":"Curr Diab Rep"},{"issue":"9","key":"748_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018, Sep, 1;24(9):1342\u201350.","journal-title":"Nat Med"},{"key":"748_CR34","doi-asserted-by":"crossref","unstructured":"Huang X, Wang H, She C, Feng J, Liu X, Hu X, et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy. Front Endocrinol. 2022;13. Frontiers Media S.A.","DOI":"10.3389\/fendo.2022.946915"},{"key":"748_CR35","doi-asserted-by":"crossref","unstructured":"Wewetzer L, Held LA, Goetz K, Steinh\u00e4user J. Determinants of the implementation of artificial intelligence-based screening for diabetic retinopathy-a cross-sectional study with general practitioners in Germany. Digit Health. 2023, Jan, 1;9.","DOI":"10.1177\/20552076231176644"},{"key":"748_CR36","doi-asserted-by":"crossref","unstructured":"Tufail A, Kapetanakis V V, Salas-Vega S, Egan C, Rudisill C, Owen CG, et al. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness. Health Technol Assess (Rockv). 2016, Dec, 1;20(92):1\u201372.","DOI":"10.3310\/hta20920"},{"key":"748_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/bjophthalmol-2020-316594","volume":"105","author":"P Heydon","year":"2021","unstructured":"Heydon P, Egan C, Bolter L, Chambers R, Anderson J, Aldington S, et al. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients. Br J Ophthalmol. 2021;105:723\u201328. BMJ Publishing Group.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"748_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ophtha.2016.11.014","volume":"124","author":"A Tufail","year":"2017","unstructured":"Tufail A, Rudisill C, Egan C, Kapetanakis V V, Salas-Vega S, Owen CG, et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders. Ophthalmology. 2017, Mar, 1;124(3):343\u201351.","journal-title":"Ophthalmology"},{"key":"748_CR39","doi-asserted-by":"crossref","unstructured":"Poly TN, Islam MM, Walther BA, Lin MC, (Jack) Li YC. Artificial intelligence in diabetic retinopathy: bibliometric analysis. Comput Methods Programs Biomed. 2023, Apr, 1;231.","DOI":"10.1016\/j.cmpb.2023.107358"},{"key":"748_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1464-5491.2009.02870.x","volume":"27","author":"S Jones","year":"2010","unstructured":"Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27:249\u201356. Blackwell Publishing Ltd.","journal-title":"Diabet Med"},{"key":"748_CR41","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1001\/jama.2016.17563","volume":"316","author":"TY Wong","year":"2016","unstructured":"Wong TY, Bressler NM. Artificial intelligence with deep learning technology looks into diabetic retinopathy screening. JAMA - J Am Med Assoc. 2016;316:2366\u201367.","journal-title":"jama - J Am Med Assoc"},{"issue":"2","key":"748_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaophthalmol.2015.5083","volume":"134","author":"OB Walton","year":"2016","unstructured":"Walton OB, Garoon RB, Weng CY, Gross J, Young AK, Camero KA, et al. Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol. 2016, Feb, 1;134(2):204\u201309.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"748_CR43","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00417-023-06145-7","volume":"261","author":"H Esmaeilkhanian","year":"2023","unstructured":"Esmaeilkhanian H, Liu H, Fasih-Ahmed S, Gnanaraj R, Verma A, Oncel D, et al. The relationship of diabetic retinopathy severity scales with frequency and surface area of diabetic retinopathy lesions. Graefe\u2019s Archiv Clin Exp Ophthalmol. 2023, Nov, 1;261(11):3165\u201376.","journal-title":"Graefe\u2019s Archiv Clin Exp Ophthalmol"},{"key":"748_CR44","doi-asserted-by":"crossref","unstructured":"Laird NM, Ware JH. Random-effects models for longitudinal data [Internet]. 1982. Available from: 38. https:\/\/www.jstor.org\/stable\/2529876.","DOI":"10.2307\/2529876"},{"key":"748_CR45","doi-asserted-by":"publisher","DOI":"10.32614\/R.manuals","volume-title":"A language and environment for statistical computing","author":"R Core Team","year":"2025","unstructured":"R Core Team. A language and environment for statistical computing. R Core Team; 2025."},{"issue":"1","key":"748_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas [Internet]. 1960;20(1):37\u201346. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-84973587732%26doi=10.1177%2f001316446002000104%26partnerID=40%26md5=c08a2e401752c42fea459ff2dee4d12f.","journal-title":"Educ Psychol Meas [Internet]"},{"key":"748_CR47","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences Second Edition."},{"issue":"11","key":"748_CR48","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/sim.7251","volume":"36","author":"Y Perera","year":"2017","unstructured":"Perera Y, Ren M, Punzalan JRB, Rudnisky CJ, de Leon AR. Binocular sensitivity and specificity of screening tests in cross-sectional diagnostic studies of paired organs. Stat Med. 2017, May, 20;36(11):1754\u201366.","journal-title":"Stat Med"},{"issue":"3","key":"748_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/09286586.2021.1939886","volume":"29","author":"MWM Wintergerst","year":"2022","unstructured":"Wintergerst MWM, Bejan V, Hartmann V, Schnorrenberg M, Bleckwenn M, Weckbecker K, et al. Telemedical diabetic retinopathy screening in a primary care setting: quality of retinal photographs and accuracy of automated image analysis. Ophthalmic Epidemiol. 2022;29(3):286\u201395.","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"748_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/bjophthalmol-2019-315394","volume":"105","author":"A Olvera-Barrios","year":"2021","unstructured":"Olvera-Barrios A, Heeren TFC, Balaskas K, Chambers R, Bolter L, Egan C, et al. Diagnostic accuracy of diabetic retinopathy grading by an artificial intelligence-enabled algorithm compared with a human standard for wide-field true-colour confocal scanning and standard digital retinal images. Br J Ophthalmol. 2021, Feb, 1;105(2):265\u201370.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"748_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1932296816628546","volume":"10","author":"M Bhaskaranand","year":"2016","unstructured":"Bhaskaranand M, Ramachandra C, Bhat S, Cuadros J, Nittala MG, Sadda S, et al. Automated diabetic retinopathy screening and monitoring using retinal fundus image analysis. J Diabetes Sci Technol. 2016, Mar, 1;10(2):254\u201361.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"748_CR52","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1111\/aos.13528","volume":"96","author":"K Wang","year":"2018","unstructured":"Wang K, Jayadev C, Nittala MG, Velaga SB, Ramachandra CA, Bhaskaranand M, et al. Automated detection of diabetic retinopathy lesions on ultrawidefield pseudocolour images. Acta Ophthalmol. 2018, Mar, 1;96(2):e168\u201373.","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"748_CR53","first-page":"1138","volume":"32","author":"R Rajalakshmi","year":"2018","unstructured":"Rajalakshmi R, Subashini R, Anjana RM, Mohan V. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye (Basingstoke). 2018, Jun, 1;32(6):1138\u201344.","journal-title":"Eye (Basingstoke)"},{"issue":"1","key":"748_CR54","first-page":"334","volume":"35","author":"TN Kim","year":"2021","unstructured":"Kim TN, Aaberg MT, Li P, Davila JR, Bhaskaranand M, Bhat S, et al. Comparison of automated and expert human grading of diabetic retinopathy using smartphone-based retinal photography. Eye (Basingstoke). 2021, Jan, 1;35(1):334\u201342.","journal-title":"Eye (Basingstoke)"},{"issue":"4","key":"748_CR55","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/1932296821999370","volume":"16","author":"N Mokhashi","year":"2022","unstructured":"Mokhashi N, Grachevskaya J, Cheng L, Yu D, Lu X, Zhang Y, et al. A comparison of artificial intelligence and human diabetic retinal image interpretation in an. Urban Health Sys J Diabetes Sci Technol. 2022, Jul, 1;16(4):1003\u201307.","journal-title":"Urban Health Sys J Diabetes Sci Technol"},{"key":"748_CR56","doi-asserted-by":"crossref","unstructured":"Cicinelli MV, Gravina S, Rutigliani C, Checchin L, La Franca L, Lattanzio R, et al. Assessing diabetic retinopathy staging with ai: a comparative analysis between pseudocolor and led imaging. Transl Vis Sci Technol. 2024, Mar, 1;13(3).","DOI":"10.1167\/tvst.13.3.11"},{"key":"748_CR57","doi-asserted-by":"crossref","unstructured":"Abr\u00e0moff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018, Dec, 1;1(1).","DOI":"10.1038\/s41746-018-0040-6"},{"key":"748_CR58","doi-asserted-by":"crossref","unstructured":"Grzybowski A, Brona P. Analysis and comparison of two artificial intelligence diabetic retinopathy screening algorithms in a pilot study: idx-dr and retinalyze. J Clin Med. 2021, Jun, 1;10(11).","DOI":"10.3390\/jcm10112352"},{"key":"748_CR59","doi-asserted-by":"crossref","unstructured":"Xu X, Zhang M, Huang S, Li X, Kui X, Liu J. The application of artificial intelligence in diabetic retinopathy: progress and prospects. Front Cell Dev Biol. Frontiers Media SA; 2024;12.","DOI":"10.3389\/fcell.2024.1473176"},{"key":"748_CR60","doi-asserted-by":"crossref","unstructured":"Haq Yasir Z, Al DH, Khandekar R. Validity of automated software supported diabetic retinopathy screening compared to digital retinal photograph evaluation by Retina Subspecialist. J Clin Exp Ophthalmol. 2018;9(4).","DOI":"10.4172\/2155-9570.1000734"},{"key":"748_CR61","doi-asserted-by":"crossref","unstructured":"K\u0105pa M, Koryciarz I, Kustosik N, Jurowski P, Pniakowska Z. Modern approach to diabetic retinopathy diagnostics. Diagnostics. 2024;14. Multidisciplinary Digital Publishing Institute (MDPI).","DOI":"10.3390\/diagnostics14171846"},{"key":"748_CR62","doi-asserted-by":"crossref","unstructured":"Abramoff MD, Mortensen Z, Tava C. Commentary: diagnosing diabetic retinopathy with artificial intelligence: what information should Be included to ensure ethical informed consent? Front Med. 2021;8. Frontiers Media S.A.","DOI":"10.3389\/fmed.2021.765936"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00748-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:53:40Z","timestamp":1763546020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00748-4","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was obtained from the Ethics Committee of Las Palmas CEI\/CEIm, under reference number 2022\u2013376\u20131. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}